JA

John Aravamuthan

Director Director DIN 00869530
DIN 00869530 First appointment Dec 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2005
Shareholding value Locked Premium profile

About John Aravamuthan

Data last updated:

John Aravamuthan has 20 years in corporate governance. Formerly with 1 company, such as Neurostimulation Medtech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 00869530
Primary Designation Director
First Appointment 21 Dec 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director21 Dec 20052005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neurostimulation Medtech Private Limited
Premium access

Shareholding and investment profile for John Aravamuthan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Aravamuthan

John Aravamuthan has 20 years in corporate governance. Formerly with 1 company, such as Neurostimulation Medtech Private Limited. Engaged in Technology. Contributes to corporate operations.

John Aravamuthan is associated with 0 companies as a director.

John Aravamuthan has expertise in Technology.

John Aravamuthan has 20 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available